iShares U.S. Healthcare ETF Rating $60.89 -0.27 (-0.44%) As of 03:58 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock iShares U.S. Healthcare ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IYH Aggregate RatingModerate Buy 2.65Holdings in IYH have an aggregate rating of Moderate Buy based on 550 analyst ratings issued in the past year covering 25 companies (80.2% of the portfolio).IYH Aggregate Price Target$60.89High Prediction$60.89Average Prediction$60.89Low Prediction$60.89Holdings in IYH have an aggregate price target of $60.89 and a range of $60.89 to $60.89 covering 25 companies (80.2% of the portfolio).IYH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares U.S. Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IYH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings11.68%LLYEli Lilly and Company$845.38+0.7%4.9914 of 5 stars2.64$938.94 11.1%25Positive NewsAnalyst Forecast8.10%JNJJohnson & Johnson$188.24-0.2%4.7153 of 5 stars2.68$189.12 0.5%22Trending NewsAnalyst Forecast7.62%ABBVAbbVie$230.16-1.6%4.6312 of 5 stars2.83$228.22 -0.8%30Positive NewsAnalyst Forecast6.00%UNHUnitedHealth Group$359.08-0.3%4.7425 of 5 stars2.46$358.95 0.0%26Trending News4.57%ABTAbbott Laboratories$133.62-0.7%4.9613 of 5 stars2.91$145.39 8.8%22Positive News3.91%MRKMerck & Co., Inc.$88.75-0.5%4.9964 of 5 stars2.32$106.41 19.9%22Positive News3.47%TMOThermo Fisher Scientific$544.14+0.2%4.8694 of 5 stars2.71$585.37 7.6%21Positive NewsAnalyst Upgrade3.07%ISRGIntuitive Surgical$449.52-0.6%4.9541 of 5 stars2.59$594.19 32.2%22Positive NewsAnalyst Upgrade2.97%AMGNAmgen$294.13-1.3%4.5988 of 5 stars2.29$309.70 5.3%21Trending NewsAnalyst Upgrade2.77%BSXBoston Scientific$96.65-0.7%4.9254 of 5 stars3.00$120.79 25.0%27Analyst DowngradeAnalyst Revision2.71%GILDGilead Sciences$113.56+0.8%4.9433 of 5 stars2.90$117.17 3.2%29Positive NewsGap Up2.64%PFEPfizer$26.44-3.4%4.8945 of 5 stars2.37$28.41 7.5%19Trending NewsAnalyst Forecast2.52%SYKStryker$365.70-1.3%4.9584 of 5 stars2.71$430.33 17.7%21Positive News2.35%DHRDanaher$211.93-1.4%4.9756 of 5 stars2.81$245.91 16.0%21Positive News2.34%MDTMedtronic$98.55+0.9%4.8429 of 5 stars2.59$100.94 2.4%22Positive NewsAnalyst Downgrade1.90%VRTXVertex Pharmaceuticals$403.110.0%4.863 of 5 stars2.62$493.81 22.5%29Positive News1.77%BMYBristol Myers Squibb$45.14-0.7%4.9921 of 5 stars2.26$56.38 24.9%23Positive NewsEx-Dividend1.47%CICigna Group$303.43-2.4%4.9993 of 5 stars2.95$371.81 22.5%19Positive NewsAnalyst Downgrade1.39%ELVElevance Health$350.10-0.1%4.6063 of 5 stars2.58$411.06 17.4%19Positive News1.34%HCAHCA Healthcare$433.90+1.0%4.7649 of 5 stars2.56$407.75 -6.0%181.25%ZTSZoetis$145.43-0.7%4.8694 of 5 stars2.50$200.88 38.1%10Positive News1.20%REGNRegeneron Pharmaceuticals$585.62-2.4%4.7533 of 5 stars2.79$817.67 39.6%29Positive News1.11%ALNYAlnylam Pharmaceuticals$451.99-1.0%4.0727 of 5 stars2.79$448.04 -0.9%29Analyst UpgradeInsider Trade1.03%BDXBecton, Dickinson and Company$191.88-0.9%4.9448 of 5 stars2.25$205.40 7.0%12Positive News1.00%IDXXIDEXX Laboratories$627.98-0.5%4.2827 of 5 stars2.75$656.50 4.5%12Positive News This page (NYSEARCA:IYH) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
